NCT00753987View on ClinicalTrials.gov

Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

January 31, 2007

Conditions
Cystic Fibrosis
Interventions
DRUG

Hypertonic Saline

5 ml of 7% saline will be administered via mask with Pari LC Plus nebuliser and a Pari Ultra Ned compressor.

Trial Locations (1)

M5G 1X8

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT00753987 - Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis | Biotech Hunter | Biotech Hunter